Systemic sclerosis is a risk factor of incident psoriasis: results from a nationwide cohort study

被引:2
作者
Kwon, Oh Chan [1 ]
Han, Kyungdo [2 ]
Park, Min-Chan [1 ]
机构
[1] Yonsei Univ, Coll Med, Dept Internal Med, Div Rheumatol, Seoul, South Korea
[2] Soongsil Univ, Dept Stat & Actuarial Sci, Seoul, South Korea
来源
FRONTIERS IN IMMUNOLOGY | 2023年 / 14卷
关键词
psoriasis; risk factor; systemic sclerosis; epidemiology; cohort; POPULATION; ASSOCIATION; DISEASE; PREVALENCE; CYTOKINES; HEALTH;
D O I
10.3389/fimmu.2023.1326298
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
ObjectiveAlthough the co-existence of systemic sclerosis (SSc) and psoriasis (PsO) has been reported, the risk relationship between the two diseases remains unclear. We aimed to assess whether SSc is associated with the risk of incident PsO.MethodsFrom the Korean National Health Insurance Service database, 4,933 patients with SSc and 24,665 age- and sex-matched controls were selected. Hazard ratios (HRs) and 95% confidence intervals (CIs) for incident PsO were estimated using multivariable Cox proportional hazard models adjusted for known risk factors of PsO. Further, we selected individuals whose health check-up data were available (2,355 patients with SSc and 11,775 age- and sex-matched controls). In this population, we further adjusted for additional risk factors of PsO using the health check-up data.ResultsIn the analysis of 4,933 patients with SSc and 24,665 age- and sex-matched controls, incidence rates of PsO in patients with SSc and controls were 10.26 and 3.20 per 1,000 person-years, respectively. After adjusting for risk factors of PsO, patients with SSc had a significantly higher risk of incident PsO (adjusted HR: 3.055 [95% CI: 2.597, 3.594]). Moreover, in the analysis of individuals who had health check-up data, additional risk factors of PsO were further adjusted; the result also showed that patients with SSc have a significantly higher risk of incident PsO (adjusted HR: 2.820 [95% CI: 2.207, 3.603]).ConclusionPatients with SSc had a 3-fold higher risk of developing incident PsO than controls, independent of known risk factors of PsO.
引用
收藏
页数:9
相关论文
共 37 条
  • [1] The Immunologic Role of IL-17 in Psoriasis and Psoriatic Arthritis Pathogenesis
    Blauvelt, Andrew
    Chiricozzi, Andrea
    [J]. CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY, 2018, 55 (03) : 379 - 390
  • [2] Association between the insertion/deletion polymorphism of the angiotensin I-converting enzyme gene and risk for psoriasis in a Chinese population in Taiwan
    Chang, Y- C.
    Wu, W- M.
    Chen, C- H.
    Lee, S- H.
    Hong, H- S.
    Hsu, L- A.
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2007, 156 (04) : 642 - 645
  • [3] Resident memory T cells in human health and disease
    Clark, Rachael A.
    [J]. SCIENCE TRANSLATIONAL MEDICINE, 2015, 7 (269)
  • [4] Systemic sclerosis
    Denton, Christopher P.
    Khanna, Dinesh
    [J]. LANCET, 2017, 390 (10103) : 1685 - 1699
  • [5] Treatment Algorithms for Systemic Sclerosis According to Experts
    Fernandez-Codina, Andreu
    Walker, Kyle M.
    Pope, Janet E.
    [J]. ARTHRITIS & RHEUMATOLOGY, 2018, 70 (11) : 1820 - 1828
  • [6] Impact of guselkumab on three cases of SSc accompanying psoriasis
    Fukasawa, Takemichi
    Yoshizaki-Ogawa, Asako
    Yoshizaki, Ayumi
    Sato, Shinichi
    [J]. RHEUMATOLOGY, 2024, 63 (01) : e6 - e8
  • [7] Incidence trends of melanoma among young adults: An epidemiologic study in Olmsted County, Minnesota
    Crum, Olivia M.
    Campbell, Elliott H.
    Reinhart, Jacob P.
    Proffer, Sydney L.
    Weaver, Amy L.
    Gibson, Lawrence E.
    Demer, Addison M.
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2023, 89 (02) : 369 - 370
  • [8] Utility of nailfold capillary assessment for predicting psoriatic arthritis based on a prospective observational cohort study
    Fukasawa, Takemichi
    Toyama, Satoshi
    Enomoto, Atsushi
    Yoshizaki-Ogawa, Asako
    Norimatsu, Yuta
    Tateishi, Shoko
    Kanda, Hiroko
    Miyagawa, Kiyoshi
    Sato, Shinichi
    Yoshizaki, Ayumi
    [J]. RHEUMATOLOGY, 2023, 62 (07) : 2418 - 2425
  • [9] Fukasawa T, 2021, ELIFE, V10, DOI [10.7554/eLife.67209, 10.7554/eLife.67209.sa0, 10.7554/eLife.67209.sa1, 10.7554/eLife.67209.sa2]
  • [10] Griffiths CEM, 2021, LANCET, V397, P1301, DOI 10.1016/S0140-6736(20)32549-6